Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.24 (
mitogen-activated protein kinase
)
95,810
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Rap1 small GTP-binding protein has the same amino acid sequence at its effector domain as that of Ras. Rap1 has been shown to antagonize the Ras functions, such as the Ras-induced transformation of NIH 3T3 cells and the Ras-induced activation of the c-Raf-1 protein kinase-dependent mitogen-activated protein (MAP) kinase cascade in Rat-1 cells, whereas we have shown that Rap1 as well as Ras stimulates DNA synthesis in Swiss 3T3 cells. We have established a cell-free assay system in which Ras activates bovine brain B-Raf protein kinase. Here we have used this assay system and examined the effect of Rap1 on the
B-Raf
activity to phosphorylate recombinant MAP kinase kinase (MEK). Recombinant Rap1B stimulated the activity of
B-Raf
, which was partially purified from bovine brain and immunoprecipitated by an anti-
B-Raf
antibody. The GTP-bound form was active, but the GDP-bound form was inactive. The fully post-translationally lipid-modified form was active, but the unmodified form was nearly inactive. The maximum
B-Raf
activity stimulated by Rap1B was nearly the same as that stimulated by Ki-Ras. Rap1B enhanced the Ki-Ras-stimulated
B-Raf
activity in an additive manner. These results indicate that not only Ras but also Rap1 is involved in the activation of the
B-Raf
-dependent
MAP kinase
cascade.
...
PMID:Activation of brain B-Raf protein kinase by Rap1B small GTP-binding protein. 857 7
Interleukin-8 (IL-8), the prototypic member of the CXC subfamily of chemokines, induces in neutrophils chemotaxis, the respiratory burst, granule release, and increased cell adhesion. The IL-8 receptor is a seven-transmembrane spanning receptor coupled to specific heterotrimeric G proteins including Gi and G16. IL-8 stimulation of its receptor on neutrophils activates Ras GTP loading and the
mitogen-activated protein kinase
(
MAPK
) pathway including Raf-1 and
B-Raf
. The properties of IL-8 stimulation of the
MAPK
pathway differ from those observed for chemoattractants such as C5a. Even though Ras GTP loading is similar for IL-8 and C5a, the maximal activation of Raf-1 and
B-Raf
is approximately 2-fold and 3-7-fold, respectively, less for IL-8 than that observed for C5a. Raf-1 activation is rapid but transient, returning to near basal levels by 10 min.
B-Raf
activation is slower in onset and does not return to basal levels for nearly 30 min. IL-8 activation of
MAPK
follows a time course suggesting an involvement of both Raf-1 and
B-Raf
. Surprisingly, wortmannin, at low concentrations, inhibits Raf-1,
B-Raf
, and
MAPK
activation in response to IL-8 and C5a demonstrating a role for phosphatidylinositol 3-kinase in the activation of Raf kinases in G protein-coupled receptor systems in human neutrophils. Furthermore, wortmannin inhibits IL-8 stimulated granule release and neutrophil adherence. These findings demonstrate the control of Raf kinases, the
MAPK
pathway and specific neutrophil functions by phosphatidylinositol 3-kinase enzymes.
...
PMID:Interleukin-8 regulation of the Ras/Raf/mitogen-activated protein kinase pathway in human neutrophils. 857 62
B-Raf
is regulated by Ras protein and acts as a mitogen-activated protein (MAP) kinase kinase kinase in PC12 cells and brain. Ras protein undergoes a series of post-translational modifications on its C-terminal CAAX motif, and the modifications are critical for its function. To elucidate the role of the post-translational modifications in interaction with, and activation of,
B-Raf
, we have analyzed a direct association between H-Ras and
B-Raf
, and constructed an in vitro system for
B-Raf
activation by H-Ras. By using methods based on inhibition of yeast adenylyl cyclase or RasGAP activity and by in vitro binding assays, we have shown that the segment of
B-Raf
corresponding to amino acid 1-326 binds directly to H-Ras with a dissociation constant (Kd) comparable to that of Raf-1 and that the binding is not significantly affected by the post-translational modifications. However, when the activity of
B-Raf
to stimulate
MAP kinase
was measured by using a cell-free system derived from rat brain cytosol, we observed that the unmodified form of H-Ras possesses an almost negligible activity to activate
B-Raf
in vitro compared to the fully modified form. H-RasSer-181,184 mutant, which was farnesylated but not palmitoylated, was equally active as the fully modified form. These results indicate that the post-translational modifications, especially farnesylation, are required for H-Ras to activate
B-Raf
even though they have no apparent effect on the binding properties of H-Ras to
B-Raf
.
...
PMID:Post-translational modification of H-Ras is required for activation of, but not for association with, B-Raf. 861 31
Activation of the
mitogen-activated protein kinase
cascade is a critical event in mitogenic growth factor signal transduction. Mitogen-activated protein kinase is directly activated by a dual specific kinase, MEK, which itself is activated by serine phosphorylation. The c-Raf kinase has been implicated in mediating the signal transduction from mitogenic growth factor receptors to MEK activation. Recently, the
B-Raf
kinase was shown to be capable of phosphorylating and activating MEK as a result of growth factor stimulation. In this report, we used the yeast two-hybrid screening to isolate MEK interacting proteins. All three members of the Raf family kinases were identified as positive clones when the mutant MEK1S218/222A, in which the two phosphorylation serine residues were substituted by alanines, was used as a bait, whereas no positive clones were isolated when the wild type MEK1 was used as a bait in a similar screening. These results suggest that elimination of the phosphorylation sites of a target protein (MEK1 in our study) may stabilize the interaction between the kinase (Raf) and its substrate (MEK1), possibly due the formation of a nonproductive complex. These observations seem to suggest a general strategy using mutants to identify the upstream kinase of a phosphoprotein or the downstream targets of a kinase. Although c-Raf and
B-Raf
have been implicated in growth factor-induced MEK activation, little is known about A-Raf. We observed that stimulation of Hela cells with epidermal growth factor resulted in a rapid and transient activation of A-Raf, which is then capable of phosphorylating and activating MEK1. Interestingly, A-Raf does not activate MEK2, although c-Raf can activate both MEK1 and MEK2. Our data demonstrated that A-Raf is, indeed, a MEK1 activator and may play a role in growth factor signaling.
...
PMID:Selective activation of MEK1 but not MEK2 by A-Raf from epidermal growth factor-stimulated Hela cells. 862 29
PC12 pheochromocytoma cells possess four known MEK activators: A-, B-, c-Raf-1 and MEKK. In order to examine whether differentiation factors or growth factors have a Raf isozyme preference for activation of the mitogenic cytoplasmic Raf-MEK-
MAPK
protein kinase cascade, the activation kinetics of these enzymes in response to epidermal growth factor (EGF) and nerve growth factor (NGF) were compared. An initial activation of all three Raf kinases was noticed, but only A- and
B-Raf
showed sustained activation by NGF, which was not seen after EGF treatment. Furthermore, expression of oncogenic versions of all three Raf kinases as well, as a potentially Raf-independent MEK activator, v-Mos, leads to activation of
MAPK
and to differentiation of PC12 cells. These data suggest a differential regulation of Raf kinases and that probably no alternative Raf substrates are involved in differentiation processes of PC12 cells.
...
PMID:Differential regulation of Raf isozymes by growth versus differentiation inducing factors in PC12 pheochromocytoma cells. 864 37
We have recently purified a Ki-Ras- and Ha-Ras-dependent
extracellular signal-regulated kinase
kinase from bovine brain and identified it as B-Raf protein kinase complexed with 14-3-3 proteins (Yamamori, B., Kuroda, S., Shimizu, K., Fukui, K., Ohtsuka, T., and Takai, Y. (1995) J. Biol. Chem. 270, 11723-11726). Moreover, we found that Rap1B as well as Ki-Ras and Ha-Ras stimulate the
B-Raf
activity. Since
B-Raf
contains a cysteine-rich domain originally found in protein kinase C as a domain responsible for interaction with phosphatidylserine (PS) and diacylglycerol or 12-O-tetradecanoylphorbol-13-acetate, we have examined here the effect of these compounds on the Ki-Ras-, Ha-Ras-, and Rap1B-induced activation of bovine brain
B-Raf
. Bovine brain PS enhanced Ki-Ras-stimulated
B-Raf
activity. Phosphatidic acid was slightly active, but other phospholipids, such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylinositol (PI), PI-4-monophosphate, PI-4,5-bisphosphate, and PI-3,4,5-trisphosphate, were inactive. However, none of the above phospholipids affected the Ha-Ras-stimulated
B-Raf
activity, whereas PI, PS, phosphatidylethanolamine, and phosphatidic acid inhibited the Rap1B-stimulated
B-Raf
activity. Phosphatidylcholine or PI-4-monophosphate did not show any effect on the Rap1B-stimulated
B-Raf
activity. Synthetic PS with two unsaturated fatty acids, such as 1,2-dioleoyl-PS or 1,2-dilinoleoyl-PS, showed the same effect toward the Ki-Ras- and Rap1B-stimulated
B-Raf
activities, but synthetic PS with two saturated fatty acids, such as 1, 2-distearoyl-PS, was inactive. 12-O-Tetradecanoylphorbol-13-acetate did not affect the stimulatory or inhibitory effect of PS on the Ki-Ras- and Rap1B-stimulated
B-Raf
activities, respectively. PS did not affect the Ki-Ras-, Ha-Ras-, or Rap1B-independent basal
B-Raf
activity or the mitogen-activated protein kinase kinase or
extracellular signal-regulated kinase
activity. These results indicate that various phospholipids differently affect Ki-Ras-, Ha-Ras, and Rap1B-induced
B-Raf
activation.
...
PMID:Different effects of various phospholipids on Ki-Ras-, Ha-Ras-, and Rap1B-induced B-Raf activation. 866 12
Recent studies suggested the existence of Ras/
B-Raf
/ MEK-1 complexes and a critical role for
B-Raf
in regulating the
MAP kinase
/ERKs signalling pathway. We report, here, that both Ras and MEK-1 proteins interact physically with
B-Raf
proteins in the yeast two-hybrid system. In addition, by screening a mouse brain cDNA library, we isolated additional
B-Raf
interacting proteins. These include three members of the 14-3-3 proteins family (eta, theta and zeta) and the MEK-2 protein. We also show that c-Raf-1, previously reported to interact with beta and zeta 14-3-3 proteins, also interacts with eta and theta 14-3-3 proteins in the two-hybrid system. By using different portions of the B-Raf protein, we mapped the regions of the protein involved in these interactions. Specifically, we have characterized
B-Raf
specific sequences required for an efficient interaction with MEK proteins. We show that, consequently,
B-Raf
interacts with MEK-1 and MEK-2 with a better affinity than does c-Raf-1, thus strengthening the notion that
B-Raf
is a stronger MEK activator than c-Raf-l. Our results also suggest that a MEK specific sequence, not present in
MAP kinase
kinases which are not activated by members of the Raf family, is required for the interaction with Raf proteins.
...
PMID:Identification of signalling proteins interacting with B-Raf in the yeast two-hybrid system. 866 48
The nerve growth factor (NGF)-mediated activation of the mitogen-activated protein (MAP) kinase cascade is an obligatory step in the morphological differentiation of PC12 cells. Signal transduction through the
MAP kinase
cascade is dependent upon activation of p21(ras) which binds directly to Raf family protein kinases, mediating their association with the membrane and activation. PC12 cells express two Raf isoforms, c-Raf and
B-Raf
. The activation of the
MAP kinase
cascade in response to NGF is due principally to the action of
B-Raf
. NGF treatment of PC12 cells resulted in the enhanced phosphorylation of
B-Raf
and c-Raf, and both exhibit reduced electrophoretic mobilities following stimulation of the cells. The NGF-stimulated phosphorylation of
B-Raf
was correlated with its enzymatic activation as measured by the phosphorylation of its substrate MEK. However, c-Raf does not exhibit significant levels of activity.
B-Raf
was present as a component of a high molecular mass complex, which included the molecular chaperone, heat shock protein 90 (HSP90). Importantly, c-Raf did not participate in the formation of such complexes. The
B-Raf
containing HSP90 complexes were normally present in PC12 cells, and their assembly was not dependent upon NGF stimulation. These data suggest that the ability of
B-Raf
to activate the
MAP kinase
cascade is due to its association with a large signaling complex, which is likely to impart signaling pathway specificity.
...
PMID:Nerve growth factor-mediated activation of the mitogen-activated protein (MAP) kinase cascade involves a signaling complex containing B-Raf and HSP90. 879 78
The Ras/Raf/MEK/
MAP kinase
cascade transmits signals from activated cell-surface receptors to transcription factors in the nucleus and is an essential component of metazoan intracellular signaling pathways (see, for example, [1-6]). In the mouse, the Raf protein kinase family is comprised of three homologous genes, Raf-1, A-Raf and
B-Raf
[5] which are ubiquitously expressed in the developing embryo [7]. We have introduced into the mouse germ line a loss-of-function mutation in the X-chromosomal A-Raf gene, by homologous recombination in embryonic stem cells. On a predominantly C57 Bl/6 genetic background, A-Raf-deficient mice displayed neurological and intestinal abnormalities and died between 7 and 21 days post-partum. When the mutated allele was maintained on a predominantly 129/OLA background, by contrast, A-Raf-deficient animals survived to adulthood, did not display obvious intestinal abnormalities, were fertile, but did have a subset of the neurological defects.
...
PMID:Post-natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase gene. 880 80
Cyclic adenosine monophosphate (cAMP) has tissue-specific effects on growth, differentiation, and gene expression. We show here that cAMP can activate the transcription factor Elk-1 and induce neuronal differentiation of PC12 cells via its activation of the
MAP kinase
cascade. These cell type-specific actions of cAMP require the expression of the serine/threonine kinase
B-Raf
and activation of the small G protein Rap1. Rap1, activated by mutation or by the cAMP-dependent protein kinase PKA, is a selective activator of
B-Raf
and an inhibitor of Raf-1. Therefore, in
B-Raf
-expressing cells, the activation of Rap1 provides a mechanism for tissue-specific regulation of cell growth and differentiation via
MAP kinase
.
...
PMID:cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. 909 16
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>